Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 24mg - lenvatinib (mésylate de lenvatinib) 24mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 20mg - lenvatinib (mésylate de lenvatinib) 20mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 14mg - lenvatinib (mésylate de lenvatinib) 14mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 10mg - lenvatinib (mésylate de lenvatinib) 10mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 8mg - lenvatinib (mésylate de lenvatinib) 8mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 18mg - lenvatinib (mésylate de lenvatinib) 18mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 4mg - lenvatinib (mésylate de lenvatinib) 4mg - antineoplastic agents
Canada -
français -
Health Canada
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 12mg - lenvatinib (mésylate de lenvatinib) 12mg - antineoplastic agents
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
kisplyx 4 mg capsules
eisai pharma ag - lenvatinibum - capsules - lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
kisplyx 10 mg capsules
eisai pharma ag - lenvatinibum - capsules - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika